v3.24.2.u1
Schedule of movements in ordinary shares (Details) - USD ($)
$ in Thousands
 1 Months Ended 6 Months Ended 12 Months Ended
Oct. 19, 2020
Jun. 30, 2021
Dec. 31, 2023
Jun. 30, 2023
Dec. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
IfrsStatementLineItems [Line Items]                
At June 30, 2021     $ 3,746 $ 15,475 $ 21,615 $ 21,615 $ 40,418 $ 17,890
Capital raises 1, Shares 3,382,350 708,669         82,644 4,091,019
Capital raises 1     596 (11) 5,065 $ 5,054 $ 122 $ 31,562
Employee share scheme issues 2, Shares           102,252 682,220 792,126
Employee share scheme issues 2     208 86 60 $ 147 $ 2,012 $ 1,077
Ending balance, value   $ 40,418 $ (4,042) 3,746 $ 15,475 $ 3,746 $ 21,615 40,418
Issued capital [member]                
IfrsStatementLineItems [Line Items]                
Balance, shares     25,651,140   21,318,118 21,318,118 18,506,064  
At June 30, 2021     $ 308 307 $ 256 $ 256 $ 222 163
Conversion of Aevitas equity instruments 3, Shares [1],[2]             2,005,190  
Conversion of Aevitas equity instruments 3 [1],[2]             $ 24  
Capital raises 1, Shares [3]           4,230,770 82,644  
Capital raises 1     64 51 $ 51 [3] $ 1 [3] 49
Other share issuance 4 [4],[5]             42,000  
Other share issuance 4 [4],[5]             $ 1  
Employee share scheme issues 2, Shares [6],[7]           102,252 682,220  
Employee share scheme issues 2     15 $ 1 $ 1 [6],[7] $ 8 [6],[7] $ 9
Balance, shares   18,506,064   25,651,140   25,651,140 21,318,118 18,506,064
Ending balance, value   $ 222 387 $ 308 307 $ 308 $ 256 $ 222
Share premium [member]                
IfrsStatementLineItems [Line Items]                
At June 30, 2021     105,018 104,867 99,418 99,418 76,229 40,215
Conversion of Aevitas equity instruments 3 [1],[2]             20,442  
Capital raises 1     599 5,449 5,449 [3] 243 [3] 34,317
Other share issuance 4 [4],[5]             217  
Employee share scheme issues 2     151 151 [6],[7] 2,287 [6],[7] 961
Ending balance, value   76,229 105,617 105,018 104,867 105,018 99,418 76,229
Issued Capital And Share Premium [Member]                
IfrsStatementLineItems [Line Items]                
At June 30, 2021     $ 105,326   $ 99,674 99,674 76,451  
Conversion of Aevitas equity instruments 3 [1],[2]             20,466  
Capital raises 1 [3]           5,500 244  
Other share issuance 4 [4],[5]             218  
Employee share scheme issues 2 [6],[7]           152 2,295  
Ending balance, value   $ 76,451   $ 105,326   $ 105,326 $ 99,674 $ 76,451
[1] On June 30, 2021, holders of convertible preference shares and convertible loan notes in Aevitas Group Limited (“Aevitas Group”), exercised their right to convert the debt instruments into Ordinary Shares in VivoPower International PLC. A total of 2,005,190 restricted Ordinary Shares were issued at a contracted price of $10.20 on July 21, 2021. Of the 2,005,190 Ordinary Shares issued, 1,959,339 were issued to entities owned by AWN, the Company’s largest individual shareholder.
[2] On June 30, 2021, holders of convertible preference shares and convertible loan notes in Aevitas Group Limited (“Aevitas Group”), exercised their right to convert the debt instruments into Ordinary Shares in VivoPower International PLC. A total of 2,005,190 restricted Ordinary Shares were issued at a contracted price of $10.20 on July 21, 2021. Of the 2,005,190 Ordinary Shares issued, 1,959,339 were issued to entities owned by AWN, the Company’s largest individual shareholder.
[3] On July 29, 2022, the Company entered into a Securities Purchase Agreement to issue and sell, in a registered direct offering directly to an investor, (i) an aggregate of 2,300,000 Ordinary Shares (the “Shares”), nominal value $0.012 per share, at an offering price of $1.30 per share and (ii) an aggregate of 1,930,770 pre-funded warrants exercisable for Ordinary Shares at an offering price of $1.2999 per pre-funded warrant, for gross proceeds of approximately $5.5 million before deducting the placement agent fee and related offering expenses. The pre-funded warrants were sold to the Investor whose purchase of Ordinary Shares in the Registered Offering would otherwise result in the Investor, together with its affiliates and certain related parties, beneficially owning more than 4.99% of the Company’s outstanding Ordinary Shares immediately following the consummation of the Registered Offering, in lieu of Ordinary Shares. Each pre-funded warrant represents the right to purchase one Ordinary Share at an exercise price of $0.0001 per share. The pre-funded warrants were exercised on November 22, 2022.
[4] During the year ended June 30, 2022, 21,000 restricted shares were issued to Corporate Profile LLC and 21,000 restricted shares were issued to FON Consulting Ltd in exchange for investor relations services.
[5] During the year ended June 30, 2022, 21,000 restricted shares were issued to Corporate Profile LLC and 21,000 restricted shares were issued to FON Consulting Ltd in exchange for investor relations services.
[6] During the year ended June 30, 2023, 102,252 shares (year ended June 30, 2022: 682,220; year ended June 30, 2021: 792,126) were issued to employees and directors of the Company and consultants to the Company under the Omnibus Incentive Plan.
[7] During the year ended June 30, 2023, 102,252 shares (year ended June 30, 2022: 682,220; year ended June 30, 2021: 792,126) were issued to employees and directors of the Company and consultants to the Company under the Omnibus Incentive Plan.